These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2380096)

  • 1. Regeneration in cervix cancer after 252Cf neutron brachytherapy.
    Maruyama Y; Wierzbicki J; Feola J; Urano M
    Int J Radiat Oncol Biol Phys; 1990 Jul; 19(1):61-7. PubMed ID: 2380096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cure of cervical cancer using 252Cf neutron brachytherapy.
    Maruyama Y; van Nagell JR; Yoneda J; Donaldson ES; Gallion HH; Higgins R; Kryscio RJ
    Strahlenther Onkol; 1990 May; 166(5):317-21. PubMed ID: 2190346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II clinical trial using californium 252 fast neutron brachytherapy, external pelvic radiation, and extrafascial hysterectomy in the treatment of bulky, barrel-shaped stage IB cervical cancer.
    van Nagell JR; Maruyama Y; Donaldson ES; Hanson MB; Gallion HH; Yoneda J; Powell DE; Kryscio RJ; Beach JL
    Cancer; 1986 May; 57(10):1918-22. PubMed ID: 3513939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specimen findings and survival after preoperative 252Cf neutron brachytherapy for stage II cervical carcinoma.
    Maruyama Y; Donaldson E; van Nagell JR; Yoneda J; Gallion HH; Powell D; Kryscio RJ
    Gynecol Oncol; 1991 Dec; 43(3):252-9. PubMed ID: 1752495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specimen histology after one or two preoperative CF-252 implants for bulky stage IB cervical cancer.
    Maruyama Y; van Nagell JR; Feola JM; Beach JL; Yoneda J; Donaldson E; Gallion H; Rowley K; Powell D
    Int J Radiat Oncol Biol Phys; 1987 Oct; 13(10):1473-8. PubMed ID: 3624026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of time-dose and fractionation for 252Cf neutrons in preoperative bulky/barrel-cervix carcinoma radiotherapy.
    Maruyama Y; Wierzbicki J
    Int J Radiat Oncol Biol Phys; 1990 Dec; 19(6):1561-8. PubMed ID: 2262382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cervical cancer clearance after 252Cf neutron brachytherapy versus conventional photon brachytherapy.
    Maruyama Y; Muir W
    Am J Clin Oncol; 1984 Aug; 7(4):347-52. PubMed ID: 6741864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of brachytherapy with californium-252 neutrons versus cesium-137 photons for eradication of bulky localized cervical cancer: single-institution study.
    Maruyama Y; van Nagell JR; Yoneda J; Donaldson E; Gallion H; Higgins R; Powell D; Turner C; Kryscio R
    J Natl Cancer Inst; 1988 Jun; 80(7):501-6. PubMed ID: 3367388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Californium-252 brachytherapy combined with external-beam radiotherapy for cervical cancer: long-term treatment results.
    Lei X; Qian CY; Qing Y; Zhao KW; Yang ZZ; Dai N; Zhong ZY; Tang C; Li Z; Gu XQ; Zhou Q; Feng Y; Xiong YL; Shan JL; Wang D
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1264-70. PubMed ID: 21435797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The preliminary report of cervical cancer treated with californium-252 neutron after loading intracavitary radiotherapy].
    Luo G; Zheng C; Shan J
    Zhonghua Fu Chan Ke Za Zhi; 2001 Dec; 36(12):742-4. PubMed ID: 16136896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A feasibility study of 252Cf neutron brachytherapy, cisplatin + 5-FU chemo-adjuvant and accelerated hyperfractionated radiotherapy for advanced cervical cancer.
    Maruyama Y; Bowen MG; Van Nagell JR; Gallion HH; DePriest P; Wierzbicki J
    Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):529-34. PubMed ID: 8005811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial of 252Cf neutron brachytherapy vs. conventional radiotherapy for advanced cervical cancer.
    Maruyama Y; Kryscio R; Van Nagell JR; Yoneda J; Donaldson E; Hanson M; Beach JL; Feola JM; Martin A; Parker C
    Int J Radiat Oncol Biol Phys; 1985 Aug; 11(8):1475-82. PubMed ID: 4019271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of californium-252 neutron brachytherapy for cervical cancer.
    Maruyama Y; van Nagell JR; Yoneda J; Donaldson ES; Gallion HH; Powell D; Kryscio RJ
    Cancer; 1991 Sep; 68(6):1189-97. PubMed ID: 1873769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutron and gamma dose distribution for tandem, tandem and ovoid and plaque for intracavitary 252Cf therapy of cervix carcinoma.
    Maruyama Y; Tai DL; Beach JL
    Radiat Med; 1983; 1(3):230-6. PubMed ID: 6390538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of 252Cf neutron intracavitary therapy for primary endometrial adenocarcinoma.
    Maruyama Y; Van Nagell JR; Yoneda J; DePriest P; Kryscio RJ
    Cancer; 1993 Jun; 71(12):3932-7. PubMed ID: 8508359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical study of relative biological effectiveness for cervical carcinoma treated by 252Cf neutrons and assessed by histological tumour eradication.
    Maruyama Y; Feola JM; Wierzbicki J; van Nagell JR; Powell D; Yoneda J
    Br J Radiol; 1990 Apr; 63(748):270-7. PubMed ID: 2112036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Californium-252 neutron brachytherapy combined with external pelvic radiotherapy plus concurrent chemotherapy for cervical cancer: a retrospective clinical study.
    Qian S; Ye L; Tian YH; Wang LG; Huang ZP; Li F; Hou B; Song N; Chen J; Liu Y; Liu X; Zhou T
    Chin J Cancer; 2017 Feb; 36(1):24. PubMed ID: 28245859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose-rate californium-252 neutron intracavitary afterloading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer.
    Zhang M; Xu HD; Pan SD; Lin S; Yue JH; Liu JR
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):966-71. PubMed ID: 22138462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Californium-252 (252Cf) versus conventional gamma radiation in the brachytherapy of advanced cervical carcinoma long-term treatment results of a randomized study.
    Tacev T; Ptácková B; Strnad V
    Strahlenther Onkol; 2003 Jun; 179(6):377-84. PubMed ID: 12789463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I-II clinical trial of Californium-252. Treatment of stage IB carcinoma of the cervix.
    Maruyama Y; VanNagell JR; Yoneda J; Donaldson E; Gallion H; Rowley K; Kryscio R; Beach JL
    Cancer; 1987 Apr; 59(8):1500-5. PubMed ID: 3028603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.